NDC Package 67877-673-62 Rufinamide

Suspension Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

67877-673-62

Package Description:

1 BOTTLE in 1 CARTON / 460 mL in 1 BOTTLE

Product Code:

67877-673

Proprietary Name:

Rufinamide

Non-Proprietary Name:

Rufinamide

Substance Name:

Rufinamide

Usage Information:

Rufinamide is used with other medications to prevent or control seizures (epilepsy) associated with Lennox-Gastaut syndrome (LGS). This medication is an anticonvulsant. Rufinamide is thought to work by acting on the sodium channels in the brain that carry excessive electrical charges that may cause seizures.

11-Digit NDC Billing Format:

67877067362

Billing Unit:

ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

NDC to RxNorm Crosswalk:

RxCUI: 1092357 - rufinamide 40 MG in 1 mL Oral Suspension

RxCUI: 1092357 - rufinamide 40 MG/ML Oral Suspension

RxCUI: 1092357 - rufinamide 40 MG per 1 ML Oral Suspension

Product Type:

Human Prescription Drug

Labeler Name:

Ascend Laboratories, Llc

Dosage Form:

Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.

Administration Route(s):

Oral - Administration to or by way of the mouth.

Active Ingredient(s):

RUFINAMIDE 40 mg/mL

Sample Package:

FDA Application Number:

ANDA213410

Marketing Category:

ANDA - A product marketed under an approved Abbreviated New Drug Application.

Start Marketing Date:

02-24-2021

Listing Expiration Date:

12-31-2025

Exclude Flag:

Code Structure:

67877 - Ascend Laboratories, Llc
- 67877-673 - Rufinamide
  - 67877-673-62 - 1 BOTTLE in 1 CARTON / 460 mL in 1 BOTTLE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 67877-673-62?

The NDC Packaged Code 67877-673-62 is assigned to a package of 1 bottle in 1 carton / 460 ml in 1 bottle of Rufinamide, a human prescription drug labeled by Ascend Laboratories, Llc. The product's dosage form is suspension and is administered via oral form.

Is NDC 67877-673 included in the NDC Directory?

Yes, Rufinamide with product code 67877-673 is active and included in the NDC Directory. The product was first marketed by Ascend Laboratories, Llc on February 24, 2021 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 67877-673-62?

The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

What is the 11-digit format for NDC 67877-673-62?

The 11-digit format is 67877067362. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	67877-673-62	5-4-2	67877-0673-62

Table of Contents